David Alan Campbell insider trades

Open-market stock purchases and sales by David Alan Campbell, President and CEO at Janux Therapeutics, Inc, from SEC Form 4 filings since Jan 3, 2022.

Recent trades

DateStockTradeValue
Jul 31, 2026JANX Janux Therapeutics, IncSold (not open market)—
Jul 8, 2026JANX Janux Therapeutics, IncBought (not open market)—
Jan 2, 2026JANX Janux Therapeutics, IncSold$111K
Jan 2, 2026JANX Janux Therapeutics, IncBought (not open market)—
Jan 2, 2026JANX Janux Therapeutics, IncBought (not open market)—

Companies traded

  • JANX Janux Therapeutics, Inc: 11 sales, last Jul 31, 2026

Get free alerts when David Alan Campbell files a new trade →